O

Oric Pharmaceuticals
D

ORIC

10.540
USD
0.15
(1.44%)
مغلق
حجم التداول
32,808
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
1,180,557,796
أصول ذات صلة المقالات
المزيد

العنوان: Oric Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.